| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/2009 | CN100448438C Application of Schizandrin A on curing drug resistance for multiple drugs of treating tumors |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473701 Substituted indazoles, compositions containing them, method of production and use |
| 01/06/2009 | US7473681 Kahalalide F |
| 01/06/2009 | US7473525 Rna; anticancer agents |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2423017C Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2344470C Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 01/06/2009 | CA2308315C N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
| 01/06/2009 | CA2113819C Novel glycoside compounds and production and use thereof |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005438 Use of Isothiocyanates Compounds in Treating Prostatic Diseases and Skin Cancer |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005435 Novel Compounds, Pharmaceutical Compositions Containing Same, and Methods of Use for Same |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005420 Inhibitors of Matrix Metallaproteinases |
| 01/01/2009 | US20090005418 such as 2-benzyl-5-(2,5-difluorophenyl)-3-phenyl-2,3-dihydroisoxazole, useful for treating cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation in mammals |
| 01/01/2009 | US20090005416 Benzimidazole derivatives |
| 01/01/2009 | US20090005411 Combinations of Organic Compounds |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090005406 Cancer Treatment Method |
| 01/01/2009 | US20090005401 Novel Compounds |
| 01/01/2009 | US20090005400 Biologically Active Aphrocallistin Compounds |
| 01/01/2009 | US20090005398 Methods For The Treatment of Central Nervous System Tumors |
| 01/01/2009 | US20090005393 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase |
| 01/01/2009 | US20090005378 Pyrrolo-pyridine kinase modulators |
| 01/01/2009 | US20090005377 Pyrazolopyridine Derivates |
| 01/01/2009 | US20090005374 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 01/01/2009 | US20090005373 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/01/2009 | US20090005356 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005338 Carbonyl-substituted titanocenes |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005332 Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides |
| 01/01/2009 | US20090005328 Methods of modulating tubulin deacetylast activity |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005307 Compositions and Methods for Detection of Colorectal Cancer |
| 01/01/2009 | US20090005305 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005302 Method, apparatus, and compound for effecting localized, non-systemic, immunogenic treatment of cancer |
| 01/01/2009 | US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors |
| 01/01/2009 | US20090005292 Novel Peptides that Bind to the Erythropoietin Receptor |
| 01/01/2009 | US20090004723 Methods and Compositions Concerning Poxviruses and Cancer |
| 01/01/2009 | US20090004672 17867, a novel human aminopeptidase |
| 01/01/2009 | US20090004302 Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004293 breast cancer, melanoma, colon cancer, leukemia and lymphoma, and other cancer cells |
| 01/01/2009 | US20090004290 Red yeast rice compound for cancer chemoprevention |
| 01/01/2009 | US20090004283 Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers |
| 01/01/2009 | US20090004247 Novel substance derived from basidiomycetes culture, method for producing it and its use |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004228 Boron neutron capture therapy; carboranes; cancer |
| 01/01/2009 | US20090004218 Antigen-Carbohydrate Conjugates |
| 01/01/2009 | US20090004213 Combination therapy using active immunotherapy |
| 01/01/2009 | US20090004211 Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004205 Prospective identification and characterization of breast cancer stem cells |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
| 01/01/2009 | US20090004180 Kifs as Modifiers of the Rho Pathway and Methods of Use |
| 01/01/2009 | US20090004173 Diagnosis and Treatment of Drug Resistant Leukemia |
| 01/01/2009 | US20090004172 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation |
| 01/01/2009 | US20090004171 Compound profiling method |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004149 Injecting directly into a tumor; cancer vaccine |
| 01/01/2009 | US20090004146 Humanised Baculovirus |
| 01/01/2009 | US20090004145 Compositions and methods involving gene therapy and proteasome modulation |
| 01/01/2009 | US20090004142 A cell therapy method for the treatment of tumors |
| 01/01/2009 | US20090004118 Multifunctional Nanoparticle Conjugates And Their Use |
| 01/01/2009 | US20090004103 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 12/31/2008 | WO2009003136A1 Substituted pyrimidine-2, 4 -diamines for treating cell proliferative disorders |
| 12/31/2008 | WO2009003110A2 Metap-2 inhibitor polϋmersomes for therapeutic administration |
| 12/31/2008 | WO2009003077A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 12/31/2008 | WO2009003061A1 Methods and compositions regarding polychalcogenide compositions |
| 12/31/2008 | WO2009002808A2 Quinazolinone compounds and methods of use thereof |
| 12/31/2008 | WO2009002807A2 Indolyl pyrrolidines for the treatment of cancer |
| 12/31/2008 | WO2009002806A1 Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 12/31/2008 | WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/31/2008 | WO2009002553A1 Methods of treating multiple myeloma and resistant cancers |
| 12/31/2008 | WO2009002538A2 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib |
| 12/31/2008 | WO2009002534A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 12/31/2008 | WO2009002469A1 Phthalazine compounds, compositions and methods of use |
| 12/31/2008 | WO2009002425A2 Solubilized formulation of docetaxel without tween 80 |